Home Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer
Article
Licensed
Unlicensed Requires Authentication

Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer

  • Murugan Kalimutho , Giovanna Del Vecchio Blanco , Paolo Gravina , Micaela Cretella , Liliana Mannucci , Elena Mannisi , Amanda Formosa , Francesco Pallone , Giorgio Federici and Sergio Bernardini
Published/Copyright: May 27, 2010

Abstract

Background: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. However, prevention is possible by early detection. In the present work, we have demonstrated and validated a novel quantitative method based on a DNA integrity assay and mutation in faeces of CRC patients using denaturing high performance liquid chromatography (dHPLC).

Methods: Faecal DNA (fDNA) was isolated from 28 CRC, 96 healthy and 61 patients with adenomas. Adenomatosis polyposis coli (APC)-Long-DNA and its mutations were analysed using dHPLC and the Sanger sequencing method. The diagnostic performance was assessed using receiver operating characteristic curve analysis.

Results: We detected APC-Long-DNA in 21/28 CRC subjects with a sensitivity of 75% and specificity of 91.7%. A cut-off ratio of 0.2317 was used for APC/β-actin. The Q-dHPLC detection limit was 0.02 ng/injection. The average initial fDNA presence based on a single gene of β-actin was 26.12±13.39 ng/mL for healthy, and 49.61±46.28 ng/mL for CRC subjects, with a sensitivity of 71.4% and a specificity of 84.4% at a cut-off value >29 ng/mL. We also detected a novel mutation at codon 1576 Lys/Glu using dHPLC.

Conclusions: This study highlights a novel application of Q-dHPLC in the DNA integrity assay, which demonstrates high performance, good reproducibility, and low cost for the CRC detection using faeces. Further studies in a larger population are needed to confirm these results.

Clin Chem Lab Med 2010;48:1303–11.


Corresponding author: Dr. Murugan Kalimutho, PhD, Department of Laboratory Medicine,“U.O.C. Clinical Molecular Biology and Biochemistry”, University Hospital Tor Vergata, Viale Oxford 81, Rome 00133, Italy Phone: +3906-20902259, Fax: +3906-20902357,

Received: 2009-12-10
Accepted: 2010;-3-15
Published Online: 2010-05-27
Published in Print: 2010-09-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Lost in translation…wallowing in transformation?
  3. Reviews
  4. Coeliac disease – a diagnostic and therapeutic challenge
  5. Advancements in anemias related to chronic conditions
  6. Opinion Paper
  7. Translations of the “Evidence-Based Medicine” concept in different languages: is it time for international standardisation?
  8. Genetics and Molecular Diagnostics
  9. Rapid detection of glycogen storage disease type Ia by DNA microarray
  10. Transfer of myxovirus-protein-A mRNA assay for interferon-β bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A 4-year experience
  11. General Clinical Chemistry and Laboratory Medicine
  12. Transferrin receptor expression on reticulocytes as a marker of iron status in dialyzed patients
  13. Quartz crystal microbalance-based biosensor for the detection of α-thalassemia 1 (SEA deletion)
  14. Retrospective analysis of 88,429 serum and urine glucose EQA results obtained from professional laboratories and medical offices participating in surveys organized by three European EQA centers between 1996 and 2007
  15. Liquid phase immunoassays utilizing magnetic markers and SQUID magnetometer
  16. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods
  17. Amniotic fluid α-fetoprotein microheterogeneity in the prenatal diagnosis of congenital disorders of glycosylation type Ia
  18. Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation
  19. Reference Values and Biological Variations
  20. Blood cell and iron status analytes of preterm and full-term infants from 20 weeks onwards during the first year of life
  21. Cancer Diagnostics
  22. Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer
  23. Rapid intraoperative parathyroid hormone assay in fine needle aspiration for differential diagnosis in thyroid and parathyroid surgery
  24. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification
  25. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test
  26. Cardiovascular Diseses
  27. Diagnostic accuracy of B-type natriuretic hormone for congenital heart disease in the first month of life
  28. Carcinoembryonic antigen concentrations in patients with acute coronary syndrome
  29. Evolution of vitamin D binding protein concentration in sera from cardiac surgery patients is determined by triglyceridemia
  30. Letters to the Editor
  31. Effect of storage temperature or collection tube type on blood methylmalonic acid concentrations measured by gas chromatography-mass spectrometry
  32. Acute porphyrias may be overlooked in patients taking methenamine hippurate
  33. Reduced plasma apolipoprotein A-V concentrations in two lecithin:cholesterol acyltransferase deficient patients
  34. Salivary calcium: a risk indicator in periodontal disease
  35. S100B protein increases in human blood and urine during stressful activity
  36. Congress Abstracts
  37. Congress of Clinical Chemistry and Laboratory Medicine 7th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) Mannheim, Germany, 29th September – 02nd October, 2010
  38. 9th National Congress of the Greek Society of Clinical Chemistry Athens, Greece, October 7 – 9, 2010
  39. 42nd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology ROME MARRIOTT PARK HOTEL, Rome (Italy), 5 – 8 October 2010
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.245/pdf
Scroll to top button